PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

It’s raining biopharma execs

Read the rest…